VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
37 hedge funds and large institutions have $234M invested in Verona Pharma in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $305M → $234M (-$71.1M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
89% less call options, than puts
Call options by funds: $4K | Put options by funds: $35K
Holders
37
Holding in Top 10
3
Calls
$4K
Puts
$35K
Top Buyers
| 1 | +$1.64M | |
| 2 | +$744K | |
| 3 | +$399K | |
| 4 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
+$58K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$22K |
Top Sellers
| 1 | -$505K | |
| 2 | -$306K | |
| 3 | -$153K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$126K |
| 5 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$99.2K |